Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $746.23 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $421.04 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $123.91 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $87.95 | 4 | $0 (2020) |
| Edwards Lifesciences Corporation | $64.33 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $34.60 | 2 | $0 (2024) |
| ATRICURE, INC. | $14.40 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $245.72 | 5 | Abbott Laboratories ($172.44) |
| 2023 | $155.90 | 3 | Abbott Laboratories ($137.74) |
| 2022 | $110.86 | 1 | Abbott Laboratories ($110.86) |
| 2020 | $43.51 | 2 | Edwards Lifesciences Corporation ($21.89) |
| 2019 | $25.21 | 1 | Novartis Pharmaceuticals Corporation ($25.21) |
| 2018 | $110.00 | 3 | Merck Sharp & Dohme Corporation ($110.00) |
| 2017 | $55.03 | 3 | Novartis Pharmaceuticals Corporation ($41.12) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $42.44 | General |
| 07/08/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $141.75 | General |
| Category: Heart Failure | ||||||
| 03/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: Cardiovascular | ||||||
| 01/17/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: Heart Failure | ||||||
| 12/12/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.16 | General |
| Category: Cardiovascular | ||||||
| 10/03/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: Heart Failure | ||||||
| 05/03/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $134.26 | General |
| Category: Heart Failure | ||||||
| 03/21/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $110.86 | General |
| Category: Heart Failure | ||||||
| 03/09/2020 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $21.89 | General |
| 02/19/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/12/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 10/11/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/25/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,480 | 4,416 | $704,571 | $237,906 |
| 2022 | 33 | 3,590 | 4,700 | $709,022 | $237,356 |
| 2021 | 35 | 3,450 | 4,617 | $660,863 | $238,797 |
| 2020 | 36 | 3,091 | 3,742 | $596,135 | $203,367 |
All Medicare Procedures & Services
181 procedure records from CMS Medicare Utilization — Page 2 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 16 | 32 | $3,104 | $1,140 | 36.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 68 | 68 | $3,400 | $1,101 | 32.4% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 19 | 19 | $4,700 | $1,077 | 22.9% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 49 | 49 | $4,459 | $1,042 | 23.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 34 | 34 | $3,026 | $956.90 | 31.6% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 12 | 12 | $3,087 | $927.20 | 30.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 86 | 86 | $2,838 | $906.53 | 31.9% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 16 | 16 | $2,560 | $882.46 | 34.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 46 | 46 | $2,300 | $753.90 | 32.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 47 | 47 | $1,551 | $528.43 | 34.1% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 57 | 57 | $1,767 | $502.14 | 28.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 34 | 35 | $2,285 | $499.26 | 21.8% |
| 93307 | Ultrasound of heart | Facility | 2023 | 12 | 12 | $1,458 | $400.89 | 27.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 61 | 63 | $3,099 | $350.14 | 11.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2023 | 25 | 25 | $1,407 | $337.15 | 24.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 25 | 25 | $1,363 | $301.46 | 22.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 104 | 107 | $986.00 | $261.45 | 26.5% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Facility | 2023 | 13 | 13 | $853.00 | $217.75 | 25.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 27 | 43 | $387.00 | $180.60 | 46.7% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 26 | 29 | $580.00 | $130.54 | 22.5% |
| 93922 | Ultrasound study of arm and leg arteries | Facility | 2023 | 12 | 12 | $468.00 | $96.13 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 530 | 685 | $167,140 | $61,593 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 160 | 241 | $79,289 | $32,601 | 41.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 224 | 227 | $78,166 | $24,903 | 31.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 305 | 305 | $45,750 | $14,769 | 32.3% |
About Dr. Lance Richards, DO
Dr. Lance Richards, DO is a Internal Medicine healthcare provider based in Fort Collins, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1396908901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lance Richards, DO has received a total of $746.23 in payments from pharmaceutical and medical device companies, with $245.72 received in 2024. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($746.23).
As a Medicare-enrolled provider, Richards has provided services to 13,611 Medicare beneficiaries, totaling 17,475 services with total Medicare billing of $917,425. Data is available for 4 years (2020–2023), covering 181 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Fort Collins, CO
- Active Since 07/03/2008
- Last Updated 12/26/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396908901
Products in Payments
- CARDIOMEMS (Device) $421.04
- MK-1242 (Drug) $110.00
- ENTRESTO (Drug) $87.95
- ELIQUIS (Drug) $18.16
- CAMZYOS (Drug) $16.44
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $14.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Collins
Steven Schuster, M.d, M.D
Internal Medicine — Payments: $347,736
Dr. Justin Strote, M.d, M.D
Internal Medicine — Payments: $65,289
Jason Mayer, M.d, M.D
Internal Medicine — Payments: $41,797
Russell Heath, Md, MD
Internal Medicine — Payments: $9,459
Allison Schneider, D.o, D.O
Internal Medicine — Payments: $6,736
Dr. Alejandro Munoz, M.d, M.D
Internal Medicine — Payments: $6,564